EP Patent

EP1908756A1 — Processes for preparation of crystalline mycophenolate sodium

Assigned to Teva Pharmaceutical Works PLC · Expires 2008-04-09 · 18y expired

What this patent protects

Provided are crystalline mycophenolate sodium forms and processes for their preparation.

USPTO Abstract

Provided are crystalline mycophenolate sodium forms and processes for their preparation.

Drugs covered by this patent

asenapine-maleate (ASENAPINE MALEATE)

Patent Metadata

Patent number: EP1908756A1
Jurisdiction: EP
Classification: —
Expires: 2008-04-09
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceutical Works PLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.